VaxArray® Coronavirus SeroAssay

Multiplex Assay Provides Simultaneous Measurement of All Related Antibodies for SARS-CoV2 Vaccine Candidates

Accelerate the speed of your coronavirus vaccine development by enabling rapid and high-quality vaccine clinical efficacy studies. Or investigate population-level seroprevalence with a rapid, multiplexed serosurveillance tool.

By utilizing spike proteins for multiple coronavirus species printed in a compact microarray format, the VaxArray Coronavirus SeroAssay enables quantitative analysis of binding patterns of antibodies in serum to a variety of coronaviruses that infect humans.


  • Fast and easy with <30 min hands on time and 2 hour time to results
  • Quantitative determination of antibodies reactive to multiple coronavirus capture antigens including SARS-Cov-1, SARS-CoV-2, MERS, HKU1, 229E, NL63, and OC43
  • High clinical specificity and low limits of detection
  • Quantitative data enables higher quality research and better understanding of immunity
  • Reduced hands on time and improved performance compared to ELISA
  • SARS-CoV-2 Spike proteins recombinantly derived from multiple expression systems


  • Preclinical animal studies
  • Confirm pre-immunization status of clinical study participants
  • Measure post-immunization immunogenicity
  • Confirm induced cross-protection against other coronaviruses
  • Seroprevalence research
  • Characterization of therapeutic antibodies and convalescent serum

Coronavirus Testing Services

Prefer InDevR to run your samples?  Inquire about our standard testing services using this kit.

Learn More

VaxArray Custom Kits

InDevR can develop a custom kit that improves your vaccine development or serological testing needs.

Learn More